Ocata Therapeutics Inc fka OCAT

[manfromjax]

No I don't think it has any thing to do with greed.
After sitting here owning OCAT for more years than I should and owning other Biotechs along the way, there is something else going on with OCAT.

I am beginning to think that since OCAT form of therapy is so new to the market, there is no benchmark for the market to base a pricing on OCAT. The market can count pills, but not RPE cells. So before OCAT will start seeing any pps increase, it will have to have been in the market space for awhile before the pps gets any traction.

For example, look at MNKD and their new (game changing) form of delivery diabetic medicine through an inhaler rather than via a needle. MNKD has been beat up almost everyday since inceptions.

So, the bottom line is: OCAT is a new unproven form of medicine, until this form of delivery has been proven to be a success in the market place, OCAT pps isn't going anywhere. This may be half a decade more.

JIMHO